SUBOPTIMAL DRUG USE AND HEALTH OUTCOMES
SUBOPTIMAL DRUG USE AND HEALTH OUTCOMES
批准号:
2769447
负责人:
JOSEPH T HANLON
金额:
$22.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-01 至 2000-08-31
关键词:
age difference aging behavioral /social science research tag chemotherapy functional ability gender difference health care cost /financing health care service utilization human data human mortality longitudinal human study outcomes research racial /ethnic difference rural area self care self medication urban area
中文摘要
这项研究的目的是确定不适当的
社区住宅健康相关结果处方
老人 不适当的处方由两个不同的标准定义:
1)不适当的药物使用,如Beers et.(1991); 2)
根据合同制定的不适当药物使用标准,
HCFA对《医疗保险灾难性覆盖法案》的回应
1988. 测量的结果包括功能状态(通过
日常生活的基本和工具性活动以及行动能力)、健康
服务利用(住院、机构化、急诊
房间和医生办公室访问)和相关的成本,以及死亡率。
调查人员计划研究是否与
不适当的处方和结果受到以下因素的影响,
年龄、性别、种族、城市/农村居住地和合并症。 一
将使用基于人群的纵向设计。 具体
要检验的假设是,与不接受教育的老年人相比,
不适当的处方,不适当的老年参与者
处方将有更大的功能下降,增加利用
卫生服务,费用增加,
控制重要的协变量(例如合并症)。 研究
将分析来自国家研究所的现有数据集,
老龄化(NIA)资助的杜克大学流行病学既定人群
老年人研究(EPES)。
英文摘要
The study's objective is to determine the impact of inappropriate
prescribing on health-related outcomes for community dwelling
elderly. Inappropriate prescribing is defined by two different criteria:
1) inappropriate medication use as defined by Beers et. al. (1991); 2)
inappropriate medication use criteria developed under contract to
HCFA in response to the Medicare Catastrophic Coverage Act of
1988. Outcomes measured include functional status (as measured by
basic and instrumental activities of daily living, and mobility), health
services utilization (hospitalization, institutionalization, emergency
room and physician office visits) and associated costs, and mortality.
Investigators plan to examine whether the relationship between
inappropriate prescribing and outcomes are affected by factors such as
age, gender, race, urban/rural residence and comorbidities. A
longitudinal design that is population based will be used. The specific
hypotheses to be tested are that, compared with elders not receiving
inappropriate prescriptions, elderly participants with inappropriate
prescribing will have greater functional decline, increased utilization of
health services, higher costs and increased likelihood of death after
controlling for important covarites (e.g. comorbidities). The study
will analyze a pre-existing data set from the National Institute on
Aging (NIA)-funded Duke Established Populations for Epidemiologic
Studies of the Elderly (EPESE).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UPITT Program for Pharmaceutical Outcomes Research in Aging
-
批准号:8115100
-
项目类别:
-
资助金额:$9.34万
-
财政年份:2009
-
负责人:JOSEPH T HANLON
-
依托单位:
Racial Disparities in Older Adults: Impact of Medicare Part D
-
批准号:7686479
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2009
-
负责人:JOSEPH T HANLON
-
依托单位:
UPITT Program for Pharmaceutical Outcomes Research in Aging
-
批准号:7939788
-
项目类别:
-
资助金额:$9.15万
-
财政年份:2009
-
负责人:JOSEPH T HANLON
-
依托单位:
UPITT Program for Pharmaceutical Outcomes Research in Aging
-
批准号:7738644
-
项目类别:
-
资助金额:$8.96万
-
财政年份:2009
-
负责人:JOSEPH T HANLON
-
依托单位:
Racial Disparities in Older Adults: Impact of Medicare Part D
-
批准号:7926962
-
项目类别:
-
资助金额:$22.39万
-
财政年份:2009
-
负责人:JOSEPH T HANLON
-
依托单位:
UPITT Program for Pharmaceutical Outcomes Research in Aging
-
批准号:8310968
-
项目类别:
-
资助金额:$9.34万
-
财政年份:2009
-
负责人:JOSEPH T HANLON
-
依托单位:
UPITT Program for Pharmaceutical Outcomes Research in Aging
-
批准号:8520134
-
项目类别:
-
资助金额:$9.34万
-
财政年份:2009
-
负责人:JOSEPH T HANLON
-
依托单位:
Longitudinal Impact of Antihypertensive Polypharmacy on Geriatric Syndromes
-
批准号:8290634
-
项目类别:
-
资助金额:$26.69万
-
财政年份:2006
-
负责人:JOSEPH T HANLON
-
依托单位:
Longitudinal Impact of Antihypertensive Polypharmacy on Geriatric Syndromes
-
批准号:8133180
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2006
-
负责人:JOSEPH T HANLON
-
依托单位:
Longitudinal Impact of CNS Polypharmacy on Geriatric Sy*
-
批准号:7388842
-
项目类别:
-
资助金额:$17.38万
-
财政年份:2006
-
负责人:JOSEPH T HANLON
-
依托单位:
Longitudinal Impact of CNS Polypharmacy on Geriatric Syn
-
批准号:7008319
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2006
-
负责人:JOSEPH T HANLON
-
依托单位:
Longitudinal Impact of CNS Polypharmacy on Geriatric Syndromes
-
批准号:7216172
-
项目类别:
-
资助金额:$17.74万
-
财政年份:2006
-
负责人:JOSEPH T HANLON
-
依托单位:
SUBOPTIMAL DRUG USE AND HEALTH OUTCOMES
-
批准号:6055476
-
项目类别:
-
资助金额:$22.67万
-
财政年份:1997
-
负责人:JOSEPH T HANLON
-
依托单位:
SUBOPTIMAL DRUG USE AND HEALTH OUTCOMES
-
批准号:2603075
-
项目类别:
-
资助金额:$21.58万
-
财政年份:1997
-
负责人:JOSEPH T HANLON
-
依托单位:
COGNITIVE IMPAIRMENT AND MEDICATION APPROPRIATENESS
-
批准号:2236282
-
项目类别:
-
资助金额:$9.39万
-
财政年份:1993
-
负责人:JOSEPH T HANLON
-
依托单位:
COGNITIVE IMPAIRMENT AND MEDICATION APPROPRIATENESS
-
批准号:3373172
-
项目类别:
-
资助金额:$19.23万
-
财政年份:1993
-
负责人:JOSEPH T HANLON
-
依托单位:
PHARMACY INTERVENTIONS FOR POLYPHARMACY IN THE ELDERLY
-
批准号:3119990
-
项目类别:
-
资助金额:$10.7万
-
财政年份:1990
-
负责人:JOSEPH T HANLON
-
依托单位:
PHARMACY INTERVENTIONS FOR POLYPHARMACY IN THE ELDERLY
-
批准号:3119989
-
项目类别:
-
资助金额:$15.63万
-
财政年份:1990
-
负责人:JOSEPH T HANLON
-
依托单位:
PHARMACY INTERVENTIONS FOR POLYPHARMACY IN THE ELDERLY
-
批准号:3119988
-
项目类别:
-
资助金额:$15.05万
-
财政年份:1990
-
负责人:JOSEPH T HANLON
-
依托单位:
海外基金